McGill researchers identify key genetic factors which can lead to cancer
November 3, 2009(PhysOrg.com) -- Researchers at McGill University have discovered a previously unknown series of interactions between genes that control whether cells become cancerous. The discovery may lead to a new generation of targeted therapies tuned to individual patients, the researchers said. Their results are published today in the journal Cancer Cell.
The researchers studied genetically engineered mice lacking the ability to produce the genes 4E-BP1 and 4E-BP2. As these genes were believed to play an important role in inhibiting cancer, the researchers expected the 4E-BP "knockout" mice (so called because the genes encoding these proteins are deleted) to exhibit highly accelerated cancer growth.
To their surprise, it simply didn't happen.
"We didn't understand what was going on," said Dr. Emmanuel Petroulakis, a post-doctoral researcher at the Sonenberg Laboratory at McGill's Faculty of Medicine and the study's first author. "We tried other experiments to try to promote the cells from these mice to become malignant, and they failed. We were shocked."
Dr. Petroulakis and study corresponding author Dr. Nahum Sonenberg - winner of the 2008 Gairdner Prize for his discoveries in the areas of protein synthesis in human cells - decided that totally unknown genetic pathways must be involved, and crossed their mice with a strain lacking another gene, p53, already known to be a master "tumour suppressor."
"Then we got what we expected," explained Dr. Petroulakis. "More than we expected. Mice with both the 4E-BP's and p53 knocked out showed enhanced tumour growth, more than we'd see just knocking out p53 alone. This proves that the 4E-BPs are indeed tumour suppressors, but only in the context of this master tumour suppressor. That's a whole new effect, a totally new concept in the literature."
The significance of the discovery may be profound, Petroulakis continued, and may explain why some cancer therapies work well in some patients and not at all in others.
"p53 is one of the most commonly mutated genes," he said. "So if it's essentially absent or non-functional in about 50 percent of patients, therapies that target the 4E-BP activity such as what is called mTOR inhibitor drugs in those patients won't work. Now we know that we've got to understand the p53 status of a tumour first, before beginning treatment with these inhibitors."
"Things are moving towards personalized medicine," he added. "Using these techniques, if we understand the other molecular signatures operating at the same time, we can better design therapies tailored towards individual patients."
"This is another fine example how basic research, which intends to provide answers to fundamental questions about molecular mechanisms of cell proliferation, leads to unexpected findings that advance our ability to understand and cure human disease" says Dr. Sonenberg.
-
Genetic breakthrough supercharges immunity to flu and other viruses
Feb 13, 2008 |
not rated yet |
0
-
Effect of mutant p53 stability on tumorigenesis and drug design
May 15, 2008 |
not rated yet |
0
-
Preventing cancer without killing cells
Mar 30, 2007 |
not rated yet |
0
-
Stabilizing cancer-fighting p53 can also shield a metastasis-promoter
May 22, 2008 |
not rated yet |
0
-
Researchers discover how tumor suppressor inhibits cell growth
Aug 07, 2008 |
not rated yet |
0
-
Engineers build first sub-10-nm carbon nanotube transistor
Feb 01, 2012 |
4.9 / 5 (31) |
30
-
Something old, something new: Evolution and the structural divergence of duplicate genes
Jan 31, 2012 |
4.6 / 5 (7) |
1
-
The hidden nanoworld of ice crystals: Revealing the dynamic behavior of quasi-liquid layers
Jan 30, 2012 |
5 / 5 (3) |
1
-
Stock market network reveals investor clustering
Jan 27, 2012 |
3.9 / 5 (23) |
8
-
Of microchemistry and molecules: Electronic microfluidic device synthesizes biocompatible probes
Jan 26, 2012 |
5 / 5 (1) |
0
-
We the immaterial soul
1 hour ago
-
Is Everyday Technology Killing Us?
Feb 08, 2012
-
Exercise and weight loss
Feb 08, 2012
-
Why do we have head aches? Our brains can't feel anything.
Feb 07, 2012
-
"The end of diseases" by David Agus, interview from Daily Show with Jon Stewart
Feb 04, 2012
-
Oncolytic adenovirus
Feb 04, 2012
- More from Physics Forums - Medical Sciences
More news stories
Study finds that anti-diabetic medication can prevent the long-term effects of maternal obesity
In a study to be presented today at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in Dallas, Texas, researchers will report findings that show that short therapy with the anti-diabetic medication ...
19 hours ago |
5 / 5 (1) |
1
FDA-approved drug rapidly clears amyloid from the brain, reverses Alzheimer's symptoms in mice
Neuroscientists at Case Western Reserve University School of Medicine have made a dramatic breakthrough in their efforts to find a cure for Alzheimer's disease. The researchers' findings, published in the journal Science, show t ...
Medicine & Health / Neuroscience
Feb 09, 2012 |
4.9 / 5 (51) |
20
|
Steroid injections prove effective in treatment of lumbar disc herniations
The use of epidural steroid injections may be a more efficient treatment option for lumbar disc herniations, according to research presented today at the American Orthopaedic Society for Sports Medicine's Specialty Day in ...
19 hours ago |
5 / 5 (1) |
0
Amateur football players not always keen on returning to play after ACL injuries
Despite the known success rates of reconstructive Anterior Cruciate Ligament (ACL) surgery, the number of high school and collegiate football players returning to play may not be as high as anticipated, say researchers presenting ...
19 hours ago |
not rated yet |
0
PRP treatment aids healing of elbow injuries say researchers
As elbow injuries continue to rise, especially in pitchers, procedures to help treat and get players back in the game quickly have been difficult to come by. However, a newer treatment called platelet rich plasma (PRP) may ...
19 hours ago |
5 / 5 (1) |
0
Walney offshore wind farm is world's biggest (for now)
(PhysOrg.com) -- The Walney wind farm on the Irish Sea--characterized by high tides, waves and windy weather--officially opened this week. The farm is treated in the press as a very big deal as the Walney ...
GPS court ruling leaves US phone tracking unclear
A US Supreme Court decision requiring a warrant to place a GPS device on the car of a criminal suspect leaves unresolved the bigger issue of police tracking using mobile phones, legal experts say.
Europeans protest controversial Internet pact
Tens of thousands of people marched in protests in more than a dozen European cities Saturday against a controversial anti-online piracy pact that critics say could curtail Internet freedom.
Europe stakes billion-dollar bet on new rocket
A pencil-slim rocket is scheduled to lift into space from South America on Monday, carrying a billion-dollar bet that Europe can grab a juicy slice of the market to place satellites in low orbit.
Netflix settlement trims 14 pct off 4Q earnings
(AP) -- Netflix pressed the rewind button on its fourth-quarter earnings after settling allegations that the video subscription service violated a consumer-privacy law.
Navy to begin tests on electromagnetic railgun prototype launcher
The Office of Naval Research (ONR)'s Electromagnetic (EM) Railgun program will take an important step forward in the coming weeks when the first industry railgun prototype launcher is tested at a facility ...